A study for a 69 year old man who takes Keppra - from FDA reports


3,266 males aged 69 (±5) who take the same drug are studied. This is a personalized study for a 69 year old male patient who has Seizure Control. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Sep, 21, 2018

3,266 males aged 69 (±5) who take Keppra are studied.


Number of reports submitted per year:

Keppra for a 69-year old man.

Information of the patient in this study:

  • Age: 69
  • Gender: male
  • Conditions: Seizure Control
  • Drugs taken:
    • Keppra (levetiracetam)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Drowsiness
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Death
  4. Fever
  5. Drug ineffective
1 - 6 months:
  1. Confusional state
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Dizziness
  4. Weakness
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
6 - 12 months:
  1. Depression
  2. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  3. Confusional state
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Self-injurious ideation
1 - 2 years:
  1. Drowsiness
  2. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  3. Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Thrombocytopenia (decrease of platelets in blood)
2 - 5 years:
  1. Balance disorder
  2. Leukopenia (less number of white blood cells in blood)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Enlarged prostate
  5. Death
5 - 10 years:
  1. Anaemia (lack of blood)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Feeling abnormal
  4. Tearfulness (excess tearing)
  5. Personality disorder
10+ years:
n/a
not specified:
  1. Fatigue (feeling of tiredness)
  2. Weakness
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Fall
  5. Thrombocytopenia (decrease of platelets in blood)

Top conditions involved for these people *:

  1. High Blood Pressure : 243 people, 7.44%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 218 people, 6.67%
  3. Preventive Health Care : 158 people, 4.84%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 136 people, 4.16%
  5. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 132 people, 4.04%

Top co-used drugs for these people *:

  1. Aspirin (148 people, 4.53%)
  2. Pantoprazole (144 people, 4.41%)
  3. Lasix (140 people, 4.29%)
  4. Decadron (135 people, 4.13%)
  5. Metformin (133 people, 4.07%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

Related publications that referenced our studies

Recent updates

General studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.